Skip to content
healthcare.dev

Orphenadrine Citrate

NDC 25021-651, orphenadrine citrate, injection, solution, from Sagent Pharmaceuticals.

Product NDC
25021-651
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090585
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-651 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ORPHENADRINE CITRATE30 mg/mL

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
25021-651-022502106510210 VIAL in 1 CARTON (25021-651-02) / 2 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c8d8596a-b81f-4b83-a2f3-a55922ca4a82
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-651
  • NADAC price for package 25021065102

    GET /v1/drugs/nadac/25021065102

Use it

Look up 25021-651 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-651 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-651. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.